Catecholamine metabolism. From molecular understanding to clinical diagnosis and treatment. Overview.
Boulton
A A
AA
Department of Psychiatry, University of Saskatchewan, Saskatoon, Canada.
Eisenhofer
G
G
D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy*; D000818:Animals; D002394:Catechol O-Methyltransferase / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D005966:Glucuronidase / Q000378:metabolism; D006801:Humans; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy; D008954:Models, Biological; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D009474:Neurons / Q000378:metabolism; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy; D015238:Sulfotransferases / Q000378:metabolism
D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D008995:Monoamine Oxidase; D002394:Catechol O-Methyltransferase; D015238:Sulfotransferases; D005966:Glucuronidase